Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Apr 2017 10:37:00 AM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1412.40 [ +0.71% ]TCS 2310.25 [ -0.02% ]

Sensex29488.26
122.96 0.42%

Nifty9157.90
38.50 0.42%

Midcap14549.99
62.07 0.43%

Smallcap15286.37
120.06 0.79%



Lupin Ltd :

 1382.50  -26.60 [-1.89%]

ISIN: INE326A01037  | NSE: LUPIN |  Industry: Pharmaceuticals - Indian - Bulk Drugs  |  BSE Code: 500257  |  Add To Watchlist

Price Information
• Open 1405.00
• High 1408.80
• Low 1380.00
• Previous Close 1409.10
• Shares Traded 3766300
• 52 Wk High Price 1750.00
• 52 Wk High Date 29-07-2016
• 52 Wk Low Price 1380.00
• 52 Wk Low Date 24-04-2017
• Face Value 2.00


Fundamentals
• Market Capital (Rs.cr) 63744.60
• EPS (Rs.)(TTM) 78.39
• P/E Ratio(TTM) 18.01
• Book Value (Rs.) 256.70
• Price to Book Value 5.50
• Equity (Rs.cr.) 90.32
• Traded Value (Rs.lac) 851.70


Corporate Actions
Ex-Date Purpose (Rs.)
2011-07-18 150% Dividend (3)
2012-07-13 160% Dividend (3.2)
2013-07-29 200% Dividend (4)
2014-02-13 150% Interim Dividend (3)
2014-07-21 150% Final dividend (3)
2015-07-14 375% Dividend (7.5)
2016-07-25 375% Dividend (7.5)


Index Names
BSE-200
BSE Sensex
BSE HC
CNX Nifty
BSE-100
BSE-500


Related Companies
Stock Name Price
BHAGAWATIOXY 43.00




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Dec, 2016 Dec, 2016 Mar, 2016
• Sales (Rs.cr) 3218.34 13157.20 11280.10
• Net Profit (Rs.cr) 859.47 3540.01 2871.35
• Net Profit Var (%) 15.00 52.00 20.00
• EPS (Rs) - 78.39 62.10
• P/E Ratio - 18.01 22.70
• Operating Profit Margin - 38.59 -
• CPS (Rs.) - - 68.80
• P/C Ratio - - 20.50
• Div% - - 375.00

Announcements
13-05-2015 Board of Lupin recommends final dividend
27-10-2015 Board of Lupin approves appoints director and CFO
28-06-2012 Lupin received final approval for Norgestimate and Ethinyl Estradiol tablets
02-08-2016 Lupin acquires branded product portfolio from Shionogi in Japan
25-02-2014 Lupin allot equity shares
23-02-2017 Lupin allots 34604 equity shares
24-03-2017 Lupin allots 46911 equity shares
13-01-2017 Lupin allots 50081 equity shares
08-02-2011 Lupin allots equity share
06-12-2010 Lupin allots equity shares
03-11-2010 Lupin announces final USFDA approval for
23-10-2012 Lupin appoints additional director
16-03-2015 Lupin completes acquisition of Pharma Dynamics, South Africa
23-04-2014 Lupin enters strategic JV with Japanese pharma company
29-01-2015 Lupin gets approval for FII investment hike
27-08-2015 Lupin gets final approval for Omeprazole Delayed-Release capsules 40 mg
04-09-2012 Lupin gets UK MHRA nod for the Irbestran tablets
30-12-2013 Lupin grants ESOP
14-12-2010 Lupin grants options
08-01-2016 Lupin grants stock options
03-09-2015 Lupin launches first ever Duloxetine 40mg Delayed-Release Capsules
15-11-2016 Lupin launches generic Activella® Tablets
16-05-2012 Lupin launches generic combivir tablets
07-03-2017 Lupin launches generic Paxil CR tablets
20-04-2015 Lupin launches Zaxine® in Canada
06-04-2016 Lupin named amongst AON Best Employers India
28-04-2016 Lupin re-introduces Methergine® Oral Tablets
16-09-2011 Lupin received final approval for the generic Lunesta
10-10-2011 Lupin received tentative approval for Irbestran tablets
31-10-2011 Lupin received tentative approval for the generic Combivir
07-07-2011 Lupin received tentative approval for the generic Lyrica
16-07-2014 Lupin receives Best Award for Learning & Development - 2014
05-07-2012 Lupin receives FDA approval for Generic LYRICA
19-10-2012 Lupin receives FDA approval for its Oral Contraceptive Kurvelo Tablets
16-02-2017 Lupin receives final approval for Moxifloxacin Hydrochloride Tablets
31-01-2012 Lupin receives tentative approval for generic Extended Release Tablets
30-12-2014 Lupin receives tentative approval for generic Prezista® Tablets
08-05-2013 Lupin Recommends Dividend
26-07-2011 Lupin settles ongoing litigation with Medicis
12-09-2014 Lupin signs definitive distribution agreement with Salix Pharmaceuticals
26-04-2012 Lupin to announce financial results
13-07-2011 Lupin to announce Q1 results
10-10-2012 Lupin to announce Q2 results
12-01-2012 Lupin to announce Q3 results
11-07-2014 Lupin to hold AGM
25-01-2014 Lupin to hold board meeting

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
21-04-2017 11137 24715 45.06 15693147 34969.00
20-04-2017 10172 27482 37.01 14523582 39045.30
19-04-2017 41352 60259 68.62 58372484 85170.20
18-04-2017 10869 25417 42.76 15385070 36116.30
17-04-2017 13325 38929 34.23 18906843 55384.50


Bulk Deals
Deal Date Client Name Type Qty Price
08-03-2016 GENESIS EMERGING MARKETS L P B 9423708 1816.67
08-03-2016 GENESIS INDIAN INVESTMENT COMPANY LIMITED S 9423708 1816.67


Block Deals
Deal Date Client Name Type Qty Price
12-08-2016 ZYMA LABORRATORIES LTD B 150000 1580.00
12-08-2016 DESHBANDHU GUPTA S 150000 1580.00
08-03-2016 NEW INDIA INVESTMENT TRUST PLC B 325000 1780.20
08-03-2016 NEW INDIA INVESTMENT COMPANY MAURITIUS LIMITED S 325000 1780.20
24-02-2016 ZYMA LABORRATORIES LTD B 300000 1770.00


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  dewan housing finance corporation  •  tata steel  •  serv  •  bharat f  •  housing development
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech